Agritech Capital

Agritech Capital

Agritech Capital operates as an investment firm targeting the agricultural technology sector—a vertical that spans biological crop inputs, precision agriculture software, indoor farming equipment, and supply-chain analytics. The firm maintains dual-office presence in Pasadena and St. Louis, two US regions with strong agtech research ecosystems, including proximity to the Donald Danforth Plant Science Center in St. Louis and the University of California's agricultural extension programs. The firm's strategy focuses on growth-stage and early-commercial companies generating revenue between $5 million and $50 million. Agritech Capital structures investments primarily through direct equity positions and occasionally through special-purpose vehicles alongside strategic co-investors. It avoids commodity farmland investments and public equities, concentrating instead on technology developers. The firm reports no public AUM figure and does not disclose individual portfolio holdings. Agritech Capital's team size and key personnel are not publicly identified. It is not affiliated with a single wealthy family, suggesting a multi-family office, institutional, or high-net-worth capital base. The firm has no disclosed philanthropic, real-asset, or operating-company subsidiaries outside its single Pasadena and St. Louis offices. No recent deal or operational event has been publicly attributed to the firm in the last 24 months. The firm's structural differentiator is its pure thematic focus on agricultural technology at a time when most multi-sector investors treat agtech as a marginal allocation. By concentrating exclusively on the sector, Agritech Capital claims deeper technical diligence and longer holding periods than generalist venture or growth firms. However, its lack of public portfolio evidence and unverifiable team composition limits external assessment of its operational depth.